α-Tricalcium Phosphate: Synthesis, Properties and Biomedical Applications
Overview
Authors
Affiliations
Nowadays, α-tricalcium phosphate (α-TCP, α-Ca(3)(PO(4))(2)) is receiving growing attention as a raw material for several injectable hydraulic bone cements, biodegradable bioceramics and composites for bone repair. In the phase equilibrium diagram of the CaO-P(2)O(5) system, three polymorphs corresponding to the composition Ca(3)(PO(4))(2) are recognized: β-TCP, α-TCP and α'-TCP. α-TCP is formed by heating the low-temperature polymorph β-TCP or by thermal crystallization of amorphous precursors with the proper composition above the transformation temperature. The α-TCP phase may be retained at room temperature in a metastable state, and its range of stability is strongly influenced by ionic substitutions. It is as biocompatible as β-TCP, but more soluble, and hydrolyses rapidly to calcium-deficient hydroxyapatite, which makes α-TCP a useful component for preparing self-setting osteotransductive bone cements and biodegradable bioceramics and composites for bone repairing. The literature published on the synthesis and properties of α-TCP is sometimes contradictory, and therefore this article focuses on reviewing and critically discussing the synthetic methods and physicochemical and biological properties of α-TCP-based biomaterials (excluding α-TCP-based bone cements).
Combined use of deproteinized bovine bone mineral and α-tricalcium phosphate using gelatin carriers.
Fujioka-Kobayashi M, Urbanova V, Lang N, Katagiri H, Saulacic N BMC Oral Health. 2025; 25(1):275.
PMID: 39984888 PMC: 11846255. DOI: 10.1186/s12903-025-05644-9.
Markelov V, Danilko K, Solntsev V, Pyatnitskaya S, Bilyalov A Sovrem Tekhnologii Med. 2025; 16(6):60-75.
PMID: 39896152 PMC: 11780588. DOI: 10.17691/stm2024.16.6.06.
Hara S, Kojima A, Furukawa A, Toyama T, Ikake H, Shimizu S Polymers (Basel). 2025; 17(2).
PMID: 39861221 PMC: 11768388. DOI: 10.3390/polym17020147.
Fernandes H, Kannan S, Alam M, Stan G, Popa A, Buczynski R Bioact Mater. 2024; 40:104-147.
PMID: 39659434 PMC: 11630650. DOI: 10.1016/j.bioactmat.2024.05.041.
Personalized bioceramic grafts for craniomaxillofacial bone regeneration.
de Carvalho A, Rahimnejad M, Oliveira R, Sikder P, Saavedra G, Bhaduri S Int J Oral Sci. 2024; 16(1):62.
PMID: 39482290 PMC: 11528123. DOI: 10.1038/s41368-024-00327-7.